Sites of the Helmholtz Centre

On 26 April 2022, the founding ceremony for the Helmholtz Institute for One Health (HIOH) took place in Greifswald. In addition to the boards of the founding partners and the President of the Helmholtz Association, Prof Otmar D. Wiestler, the Federal Minister of Education and Research, Bettina Stark-Watzinger, and the State Minister for Science, Culture, Federal and European Affairs, Bettina Martin, were also present at the founding ceremony.

Find the programme of the founding ceremony here.

Founded in 1456, the University of Greifswald is one of the oldest universities in Germany. Today, the university is an internationally recognized research university offering outstanding study conditions in modern buildings with an excellent infrastructure for research-led teaching. Cutting-edge research originates from the intensive interdisciplinary collaboration of the faculties with renowned regional, national and international research partners. An excellent research infrastructure is available to University’s scientists, including two interfaculty research buildings of national importance as well as an outstanding (meta)proteomics platform. Infection research at the university is based on interdisciplinary and cross-faculty research networks addressing important bacterial pathogens, diagnostics and therapy of infections, bacto-viral co-infections, spread of antimicrobial resistances, human and environmental microbiomes and bats as potential pathogen reservoir.

With its combination of population-oriented, epidemiological Community Medicine and state-of-the-art Molecular Medicine, the University Medicine Greifswald (UMG) has successfully developed a unique research profile in the past decades. The “Study of Health in Pomerania (SHIP)”, launched in 1997, is one of the most comprehensive longitudinal cohort studies, covering a vast array of phenotypic and genotypic characterization. The UMG is a partner site of the German Centre for Cardiovascular Research (DZHK) and the German Centre for Neurodegenerative Diseases (DZNE). With the newly established KAS+ project, the next step has been taken to make clinical information available for research. As infection and inflammation is one of UMG’s focus topics, the UMG offers access to clinical and health care settings to jointly generate much-needed knowledge and strategies to contain the persisting threat and health burden of infectious diseases.

Founded by Friedrich Loeffler in 1910, the FLI, the Federal Research Institute for Animal Health, is an independent federal authority under the auspices of the Federal Ministry for Food and Agriculture that focuses on research for the health and well-being of food-producing animals and the protection of humans from zoonoses. With its recently completed state-of-the-art laboratories and experimental animal facilities up to biosafety level 4 located at its headquarters Greifswald-Insel Riems, it is one the most modern infectious disease research institutes in the world. Its research is based on Federal Animal Health Legislation including the operation of national and international reference laboratories for notifiable and reportable infectious animal diseases and zoonoses, e.g. caused by Influenza virus, Coronavirus, Coxiella, and Mycobacteria.

Further Information about the institue: 

Sites of the FLI
Image Flyer of the FLI
History Flyer of the FLI